title: Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation.
abstract: There is an increased incidence of tumors of the genitourinary tract among kidney graft recipients. From 1979 to 2001, all patients who received kidney transplants had records of both their underlying diseases and their initial immunosuppression. Patients who developed a genitourinary tract malignancy were evaluated for tumor type, location, stage, tumor therapy and clinical course. During this period, 1804 patients underwent 2068 kidney transplantations. Thirty-four patients had 39 tumors of genitourinary origin. One patient was lost to follow-up. There were 15 patients with 18 renal cell carcinomas (one of them multifocal): six had seven transitional cell carcinomas; six, prostatic carcinoma; six, tumor of the female genital tract (one also had a renal cell carcinoma); and two, a seminoma. Most tumors were diagnosed in their early stages (< or = pT3, N0, M0; n = 31 tumors) and thus accessible to curative therapy, achieving good long-term results: 1- and 5-year survival rates of 100% and 91%, which were better than those obtained in advanced stages (N+, M+; n = 7 tumors), namely both 1- and 5-year survival rates of 38% (P < .05). Death was caused by tumor growth in nine patients (27%) and by other causes in three patients (9%). With appropriate treatment genitourinary tumors at early stage show a good prognosis. New immunosuppressants with supposed antiproliferative effects may help to decrease the incidence of malignancies. The most important factor is risk-adapted screening to identify malignancies early and to initiate appropriate therapy.
authors.affiliation: Department of General Surgery, Muenster University Hospital, Waldeyer Strasse 1, FRG, NRW, Munster 48149, Germany. diller@uni-muenster.de
authors.forename: R
authors.initials: R
authors.lastname: Diller
authors.forename: A
authors.initials: A
authors.lastname: Gruber
authors.forename: H
authors.initials: H
authors.lastname: Wolters
authors.forename: N
authors.initials: N
authors.lastname: Senninger
authors.forename: H-U
authors.initials: HU
authors.lastname: Spiegel
mesh_terms: D002292:Carcinoma, Renal Cell / Q000453:epidemiology; D005260:Female; D005833:Genital Neoplasms, Female / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D007680:Kidney Neoplasms / Q000453:epidemiology; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000453:epidemiology; D012008:Recurrence; D012086:Reoperation; D012189:Retrospective Studies; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology; D014565:Urogenital Neoplasms / Q000453:epidemiology* / Q000628:therapy*